<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: Marine <z:chebi fb="0" ids="35191">triterpene</z:chebi> <z:chebi fb="0" ids="24400">glycosides</z:chebi> that are physiologically active natural compounds isolated from sea cucumbers (holothurians) and sponges have antifungal, cytotoxic, and antitumor activities, whose specific molecular mechanisms remain to be elucidated </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, we examined if and through which mechanisms stichoposide C (STC) from Thelenota anax (family Stichopodidae) induces <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in <z:hpo ids='HP_0001909'>leukemia</z:hpo> and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells </plain></SENT>
<SENT sid="2" pm="."><plain>EXPERIMENTAL DESIGN: We examined STC-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in human <z:hpo ids='HP_0001909'>leukemia</z:hpo> and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells in the context of <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> injury and signaling pathway disturbances, and investigated the antitumor effect of STC in mouse CT-26 subcutaneous <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> and <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>-60 <z:hpo ids='HP_0001909'>leukemia</z:hpo> <z:e sem="disease" ids="C1520166" disease_type="Experimental Model of Disease" abbrv="">xenograft models</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: We found that STC induces <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in these cells in a dose-dependent manner and leads to the activation of Fas and caspase-8, cleavage of Bid, <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> damage, and activation of caspase-3 </plain></SENT>
<SENT sid="4" pm="."><plain>STC activates acid sphingomyelinase (SMase) and neutral SMase, which resulted in the generation of <z:chebi fb="7" ids="17761">ceramide</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>Specific inhibition of acid SMase or neutral SMase and siRNA knockdown experiments partially blocked STC-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="6" pm="."><plain>Moreover, STC markedly reduced <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> of <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>-60 xenograft and CT-26 subcutaneous <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> and increased <z:chebi fb="7" ids="17761">ceramide</z:chebi> generation in vivo </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: <z:chebi fb="7" ids="17761">Ceramide</z:chebi> generation by STC, through activation of acid and neutral SMase, may in part contribute to STC-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and antitumor activity </plain></SENT>
<SENT sid="8" pm="."><plain>Thus, STC may have therapeutic relevance for human <z:hpo ids='HP_0001909'>leukemia</z:hpo> and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>